Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 365242

1.

Performance of four published risk models to predict sentinel lymph-node involvement in Australian women with early breast cancer.

Elmadahm A, Lord SJ, Hudson HM, Lee CK, Buizen L, Farshid G, Gebski VJ, Gill PG.

Breast. 2018 Jun 26;41:82-88. doi: 10.1016/j.breast.2018.05.011. [Epub ahead of print]

PMID:
30007272
2.

Quality of life evolution in elderly survivors with localized breast cancer treated with radiotherapy over a three-year follow-up.

Arraras JI, Manterola A, Illarramendi JJ, Asin G, de la Cruz S, Ibañez B, Galbete A, Salgado E, Zarandona U, Vera R, Dominguez MA, Martinez E.

Breast. 2018 Jun 22;41:74-81. doi: 10.1016/j.breast.2018.06.010. [Epub ahead of print]

PMID:
30007271
3.

Omission of chemotherapy for low-grade, luminal A N1 breast cancer: Patterns of care and clinical outcomes.

Haque W, Verma V, Hatch S, Klimberg VS, Butler EB, Teh BS.

Breast. 2018 Jul 2;41:67-73. doi: 10.1016/j.breast.2018.06.014. [Epub ahead of print]

PMID:
30007270
4.

Stereotactic radiotherapy in metastatic breast cancer.

Possanzini M, Greco C.

Breast. 2018 Jun 28;41:57-66. doi: 10.1016/j.breast.2018.06.011. [Epub ahead of print] Review.

PMID:
30007269
5.

Prospective study to optimize care and improve knowledge on ovarian function and/or fertility preservation in young breast cancer patients: Results of the pilot phase of the PREgnancy and FERtility (PREFER) study.

Lambertini M, Fontana V, Massarotti C, Poggio F, Dellepiane C, Iacono G, Abate A, Miglietta L, Ferreccio C, Pescio MC, Conte B, Blondeaux E, Bighin C, D'Alonzo A, Vaglica M, Zanardi E, Boccardo F, Ballestrero A, Anserini P, Del Mastro L.

Breast. 2018 Jun 22;41:51-56. doi: 10.1016/j.breast.2018.06.012. [Epub ahead of print]

PMID:
30007268
6.

Link between estrogen deficiency osteoporosis and susceptibility to bone metastases: A way towards precision medicine in cancer patients.

Salamanna F, Borsari V, Contartese D, Nicoli Aldini N, Fini M.

Breast. 2018 Jun 22;41:42-50. doi: 10.1016/j.breast.2018.06.013. [Epub ahead of print] Review.

PMID:
30007267
7.

Novel mechanism of cannabidiol-induced apoptosis in breast cancer cell lines.

Sultan AS, Marie MA, Sheweita SA.

Breast. 2018 Jun 22;41:34-41. doi: 10.1016/j.breast.2018.06.009. [Epub ahead of print]

PMID:
30007266
8.

Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.

Sixou S, Müller K, Jalaguier S, Kuhn C, Harbeck N, Mayr D, Engel J, Jeschke U, Ditsch N, Cavaillès V.

Transl Oncol. 2018 Jul 11;11(5):1090-1096. doi: 10.1016/j.tranon.2018.06.006. [Epub ahead of print]

PMID:
30007204
9.

Breast Cancer Screening Program in Morocco: Status of implementation, organization and performance.

Basu P, Selmouni F, Belakhel L, Sauvaget C, Abousselham L, Lucas E, Muwonge R, Sankaranarayanan R, Khazraji YC.

Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31749. [Epub ahead of print]

PMID:
30006933
10.

Towards a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multi-center study (CTCTrap).

Andree KC, Mentink A, Zeune LL, Terstappen LWMM, Stoecklein NH, Neves RP, Driemel C, Lampignano R, Yang L, Neubauer H, Fehm T, Fischer JC, Rossi E, Manicone M, Basso U, Marson P, Zamarchi R, Loriot Y, Lapierre V, Faugeroux V, Oulhen M, Farace F, Fowler G, Sousa Fontes M, Ebbs B, Lambros M, Crespo M, Flohr P, de Bono JS.

Int J Cancer. 2018 Jul 14. doi: 10.1002/ijc.31752. [Epub ahead of print]

PMID:
30006930
11.

Specific Features of Transcription Activity of Cancer-Testis Antigens in Patients with Metastatic and Non-Metastatic Breast Cancer.

Vodolazhsky DI, Kutilin DS, Mogushkova KA, Kit OI.

Bull Exp Biol Med. 2018 Jul 14. doi: 10.1007/s10517-018-4175-x. [Epub ahead of print]

PMID:
30006881
12.

Cost-effectiveness of monitoring endoxifen levels in breast cancer patients adjuvantly treated with tamoxifen.

van Nuland M, Vreman RA, Ten Ham RMT, de Vries Schultink AHM, Rosing H, Schellens JHM, Beijnen JH, Hövels AM.

Breast Cancer Res Treat. 2018 Jul 13. doi: 10.1007/s10549-018-4886-8. [Epub ahead of print]

PMID:
30006796
13.

Screening status, tumour subtype, and breast cancer survival: a national population-based analysis.

O'Brien KM, Mooney T, Fitzpatrick P, Sharp L.

Breast Cancer Res Treat. 2018 Jul 13. doi: 10.1007/s10549-018-4877-9. [Epub ahead of print]

PMID:
30006795
14.

Triple Mapping to Optimize Axillary Management in Breast Cancer Patients After Neoadjuvant Therapy.

Shilad S, Cakmakoglu C, Schwarz G, Valente S, Djohan R, Grobmyer S.

Ann Surg Oncol. 2018 Jul 13. doi: 10.1245/s10434-018-6645-9. [Epub ahead of print] No abstract available.

PMID:
30006690
15.

Molecular biology as a tool for the treatment of cancer.

de Castro Sant' Anna C, Junior AGF, Soares P, Tuji F, Paschoal E, Chaves LC, Burbano RR.

Clin Exp Med. 2018 Jul 13. doi: 10.1007/s10238-018-0518-1. [Epub ahead of print] Review.

PMID:
30006681
16.

Assessing health-related quality of life in patients with breast cancer: a reply to Ribi et al.

Maratia S, Cedillo S, Rejas J.

Qual Life Res. 2018 Jul 13. doi: 10.1007/s11136-018-1927-z. [Epub ahead of print] No abstract available.

PMID:
30006665
17.

Iodine-125 labeled Australian frog tree host-defense peptides caerin 1.1 and 1.9 better inhibit human breast cancer cells growth than the unlabeled peptides. 125I-caerin 1.9 may better be used for the treatment of breast cancer.

Yuan J, You X, Ni G, Wang T, Cavezza S, Pan X, Liu X.

Hell J Nucl Med. 2018 Jul 12. pii: s002449910803. doi: 10.1967/s002449910803. [Epub ahead of print]

PMID:
30006645
18.

More accurate than MRI measurement of tumor size in breast cancer by using the peri-tumoral halo uptake layer method of the 18F-FDG PET/CT scan.

Park SH, Seo M, Choi HJ, Bae K, Bang M, Jun S.

Hell J Nucl Med. 2018 Jul 12. pii: s002449910802. doi: 10.1967/s002449910802. [Epub ahead of print]

PMID:
30006644
19.

Chemosensitivity profiling of osteosarcoma tumour cell lines identifies a model of BRCAness.

Holme H, Gulati A, Brough R, Fleuren EDG, Bajrami I, Campbell J, Chong IY, Costa-Cabral S, Elliott R, Fenton T, Frankum J, Jones SE, Menon M, Miller R, Pemberton HN, Postel-Vinay S, Rafiq R, Selfe JL, von Kriegsheim A, Munoz AG, Rodriguez J, Shipley J, van der Graaf WTA, Williamson CT, Ryan CJ, Pettitt S, Ashworth A, Strauss SJ, Lord CJ.

Sci Rep. 2018 Jul 13;8(1):10614. doi: 10.1038/s41598-018-29043-z.

PMID:
30006631
20.

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases.

Gril B, Paranjape AN, Woditschka S, Hua E, Dolan EL, Hanson J, Wu X, Kloc W, Izycka-Swieszewska E, Duchnowska R, Pęksa R, Biernat W, Jassem J, Nayyar N, Brastianos PK, Hall OM, Peer CJ, Figg WD, Pauly GT, Robinson C, Difilippantonio S, Bialecki E, Metellus P, Schneider JP, Steeg PS.

Nat Commun. 2018 Jul 13;9(1):2705. doi: 10.1038/s41467-018-05030-w.

PMID:
30006619

Supplemental Content

Loading ...
Support Center